What more can we learn from DTC advertising? FDA's OPDP proposes new research

What more can we learn from DTC advertising? FDA's OPDP proposes new research

Source: 
Endpoints
snippet: 

How do specifics around endorsements, mechanism of action and medication tracking in pharmaceutical ads impact consumers? That’s what the FDA’s Office of Prescription Drug Promotion (OPDP) wants to find out in three new studies.